Abstract:Background: TIM-4, the only TIM protein not expressed on T cells, is found on macrophages and dendritic cells. As an innate immunity-driven local inflammation response, we hypothesized that TIM-4 signaling may play a role in the mechanism of liver IRI. Methods&Results: Unlike in sham controls, the ischemia insult triggered TIM-4 mRNA expression in mouse livers subjected to warm ischemia (90min) and reperfusion (0-24h). Its levels increased progressively, peaking by 6h of reperfusion, and declining at 12-24h. TIM-4 expression correlated with the kinetics of hepatocellular damage (sALT levels), and macrophage infiltration/activation, both peaking at 6h of reperfusion. Indeed, TIM-4 KO or WT (B/6) mice treated with antagonistic TIM-4 mAb (RMT4-53; 0.5 mg i.v. at -1h) were resistant against liver IRI, as shown by sALT levels, hepatic architecture (no edema, vacuolization/necrosis), and Suzuki’s histological score. Unlike in controls, TIM-4 blockade/ablation decreased hepatic CD68+ macrophage sequestration. Although TLR2, TLR4, and TLR9 were all induced in Ig-treated IR-stressed livers, their levels were suppressed in TIM-4 KO groups, along with diminished pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). To document the function of TIM-4+ macrophages, we have developed a new model of liver IRI in which CD11b-DTR mice were adoptively transferred with syngeneic bone marrow macrophages (BMM; 5×106 cells i.v. at day -1). After DT treatment at day -2 (circulating CD11b <0.2%), CD11b-DTR mice remained uniformly IR-resistant, compared with PBS-controls. Interestingly, unlike WT BMM, which recreated liver IRI after adoptive transfer in CD11b-DTR test mice, infusion of TIM-4-deficient BMM failed to trigger IRI, as shown by diminished sALT levels, well-preserved liver architecture, and decreased Suzuki’s histological score. Of note, consistently heightened TNF-α, IL-1β, and IL-6 levels in CD11b-DTR mice repopulated with TIM-4 proficient (WT) BMM were diminished after infusion of TIM-4 deficient (KO) BMM. Conclusion: This study provides new evidence that: 1) IR-stressed liver macrophages express TIM-4; 2) Disruption of TIM-4 signaling ameliorates liver IRI; and 3) TIM-4 signaling is critically required for macrophage activation in the mechanism of liver IR-damage. Hence, modulation of physiological TIM-4 expression provides the basis for novel therapeutic strategies against organ IRI in transplant recipients.

Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury

The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction

YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury

The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia–Reperfusion Injury

KEAP1-NRF2 Complex in Ischemia-Induced Hepatocellular Damage of Mouse Liver Transplants

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

Spatial transcriptomics analysis of zone-dependent hepatic ischemia-reperfusion injury murine model

Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments

CX3CR1 deficiency promotes resolution of hepatic ischemia-reperfusion injury by regulating homeostatic function of liver infiltrating macrophages

T-Cell Immunoglobulin and Mucin Domain 4 (Tim-4) Signaling in Innate Immune-Mediated Liver Ischemia-Reperfusion Injury (Iri)

Role of Reactive Oxygen Species in Mediating Hepatic Ischemia-Reperfusion Injury and Its Therapeutic Applications in Liver Transplantation

Myeloid spatial and transcriptional molecular signature of ischemia-reperfusion injury in human liver transplantation

Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation

MSR1-dependent efferocytosis improved ischemia-reperfusion injury following aged-donor liver transplantation in mice by regulating the pro-resolving polarization of macrophages

Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis

Novel Targets and Therapeutic Strategies to Protect Against Hepatic Ischemia Reperfusion Injury

Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment

IGF2BP3/HIF1A/YAP signaling plays a role in driving acute-on-chronic liver failure through activating hepatocyte reprogramming

Myeloid-derived suppressor cells-induced exhaustion of CD8 + T-cell participates in rejection after liver transplantation

Hepatocyte-derived extracellular vesicles miR-122-5p promotes hepatic ischemia reperfusion injury by regulating Kupffer cell polarization